Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Nanoscale Adv ; 4(24): 5343-5354, 2022 Dec 06.
Artículo en Inglés | MEDLINE | ID: mdl-36540114

RESUMEN

Titanium dioxide, or titania, is perhaps the most well-known and widely studied photocatalytic material, with myriad applications, due to a high degree of tunability achievable through the incorporation of dopants and control of phase composition and particle size. Many of the applications of titanium dioxide require particular forms, such as gels, coatings, or thin films, making the development of hybrid solution processable nanoparticles increasingly attractive. Here we report a simple solvothermal route to highly dispersible anatase phase titanium dioxide hybrid nanoparticles from amorphous titania. Solvothermal treatment of the amorphous titania in trifluoroacetic acid leads to the formation of anatase phase nanoparticles with a high degree of size control and near complete surface functionalisation. This renders the particles highly dispersible in simple organic solvents such as acetone. Dopant ions may be readily incorporated into the amorphous precursor by co-precipitation, with no adverse effect on subsequent crystallisation and surface modification.

2.
Vopr Pitan ; (1): 52-5, 1975.
Artículo en Ruso | MEDLINE | ID: mdl-54991

RESUMEN

The effect of a long-term peroral introduction of oxymethylfurfurol on the organism of albino rats was studied. The compound was administered to rats via a tube 6 days in a week for 11 months in doses of 40, 80 and 160 mg/kg with controls receiving water in place of the oxymethylfurfurol. The rats receiving 160 mg of oxymethylfurfurol per kg of body weight demonstrated a temporary rise in the level of gamma-globulin in the blood serum, an increase in the relative weight of the spleen, a tendency towards a greater activity of tributyrinase in the hepatic tissue. Dases of 40 and 80 mg/kg did not affect the protein and lipids metabolism characteristics under study, the suprarenal content of ascorbic acid, the activity of the liver succinate-dehydrogenase, the morphological structure of the internal organs, nor the general condition and dynamic changes in the weight of the animals. From the results obtained it follows that the possibility of any toxic action of oxymethylfurfurol on the albino rats with its peroral administration in a dose of 80 mg/kg and below is ruled out. By adopting a 40-fold safety margin the acceptable daily intake (ADI) of oxymethylfurfurol with food of man is estimated at up to 2 mg/kg of body weight.


Asunto(s)
Alimentos/normas , Furaldehído/análogos & derivados , Administración Oral , Animales , Ácido Ascórbico/metabolismo , Electroforesis de las Proteínas Sanguíneas , Peso Corporal/efectos de los fármacos , Butirilcolinesterasa/metabolismo , Colesterol/sangre , Relación Dosis-Respuesta a Droga , Furaldehído/farmacología , Lipasa/metabolismo , Hígado/efectos de los fármacos , Hígado/enzimología , Concentración Máxima Admisible , Ratas , Succinato Deshidrogenasa/metabolismo , Factores de Tiempo , gammaglobulinas/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA